AT369263B - Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates - Google Patents

Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates

Info

Publication number
AT369263B
AT369263B AT0433880A AT433880A AT369263B AT 369263 B AT369263 B AT 369263B AT 0433880 A AT0433880 A AT 0433880A AT 433880 A AT433880 A AT 433880A AT 369263 B AT369263 B AT 369263B
Authority
AT
Austria
Prior art keywords
ahf
producing
factor viii
high concentrate
concentrate
Prior art date
Application number
AT0433880A
Other languages
English (en)
Other versions
ATA433880A (de
Inventor
Otto Schwarz
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT0433880A priority Critical patent/AT369263B/de
Priority to SE8104482A priority patent/SE459639B/sv
Priority to NL8103563A priority patent/NL8103563A/nl
Priority to US06/287,912 priority patent/US4404131A/en
Priority to DE3129987A priority patent/DE3129987C2/de
Priority to HU812315A priority patent/HU183542B/hu
Priority to GB8124600A priority patent/GB2083047B/en
Priority to DK360281A priority patent/DK156764C/da
Priority to BE0/205702A priority patent/BE890003A/fr
Priority to ES504859A priority patent/ES504859A0/es
Priority to CA000384242A priority patent/CA1160567A/en
Priority to FI812567A priority patent/FI72653C/fi
Priority to FR8116169A priority patent/FR2489150A1/fr
Priority to AR286519A priority patent/AR228874A1/es
Priority to LU83577A priority patent/LU83577A1/de
Priority to CH5443/81A priority patent/CH652030A5/de
Priority to NO812905A priority patent/NO157884C/no
Priority to JP56134808A priority patent/JPS5928537B2/ja
Priority to IT23660/81A priority patent/IT1138511B/it
Publication of ATA433880A publication Critical patent/ATA433880A/de
Application granted granted Critical
Publication of AT369263B publication Critical patent/AT369263B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT0433880A 1980-08-27 1980-08-27 Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates AT369263B (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
AT0433880A AT369263B (de) 1980-08-27 1980-08-27 Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
SE8104482A SE459639B (sv) 1980-08-27 1981-07-22 Foerfarande foer framstaellning av ett faktor viii (amf)-hoegkoncentrat
NL8103563A NL8103563A (nl) 1980-08-27 1981-07-28 Werkwijze voor het bereiden van een hoogconcentraat van de factor viii (ahf).
US06/287,912 US4404131A (en) 1980-08-27 1981-07-29 Method of producing a factor-VIII(AHF)-high-concentrate
DE3129987A DE3129987C2 (de) 1980-08-27 1981-07-29 Verfahren zur Herstellung eines Faktor VIII(AHF)-Hochkonzentrates
HU812315A HU183542B (en) 1980-08-27 1981-08-11 Process for producing concentrated viii-bracket-ahf-bracket closed-factor
GB8124600A GB2083047B (en) 1980-08-27 1981-08-12 Improvements in or relating to a method of producing a factor-viii(ahf)-high concentrate
DK360281A DK156764C (da) 1980-08-27 1981-08-13 Fremgangsmaade til fremstilling af et faktor viii-(ahf)-hoejkoncentrat
BE0/205702A BE890003A (fr) 1980-08-27 1981-08-18 Procede de preparation d'un conclintre a forte teneur en facteur viii
CA000384242A CA1160567A (en) 1980-08-27 1981-08-20 Method of producing a factor-viii(ahf)-high- concentrate
FI812567A FI72653C (fi) 1980-08-27 1981-08-20 Foerfarande foer framstaellning av ett faktor viii(ahf)-koncentrat.
ES504859A ES504859A0 (es) 1980-08-27 1981-08-20 Procedimiento para la preparacion de un alto concentrado de factor viii (ahf).
AR286519A AR228874A1 (es) 1980-08-27 1981-08-24 Procedimiento para la preparacion de un alto concentrado de factor viii(ahf)
LU83577A LU83577A1 (de) 1980-08-27 1981-08-24 Verfahren zur herstellung eines faktor viii(ahf)-hochkonzentrates
FR8116169A FR2489150A1 (fr) 1980-08-27 1981-08-24 Procede de preparation d'un concentre a forte teneur en facteur viii
CH5443/81A CH652030A5 (de) 1980-08-27 1981-08-24 Verfahren zur herstellung eines faktor-viii-hochkonzentrates aus blutplasma.
NO812905A NO157884C (no) 1980-08-27 1981-08-26 Fremgangsmaate for fremstilling av et faktor viii(ahf)-hoeykonsentrat.
JP56134808A JPS5928537B2 (ja) 1980-08-27 1981-08-26 フアクタ−８高濃縮物の製造方法
IT23660/81A IT1138511B (it) 1980-08-27 1981-08-27 Procedimento per la produzione di un concentrato spinto di fattore viii(ahf)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0433880A AT369263B (de) 1980-08-27 1980-08-27 Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates

Publications (2)

Publication Number Publication Date
ATA433880A ATA433880A (de) 1982-05-15
AT369263B true AT369263B (de) 1982-12-27

Family

ID=3562706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0433880A AT369263B (de) 1980-08-27 1980-08-27 Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates

Country Status (19)

Country Link
US (1) US4404131A (de)
JP (1) JPS5928537B2 (de)
AR (1) AR228874A1 (de)
AT (1) AT369263B (de)
BE (1) BE890003A (de)
CA (1) CA1160567A (de)
CH (1) CH652030A5 (de)
DE (1) DE3129987C2 (de)
DK (1) DK156764C (de)
ES (1) ES504859A0 (de)
FI (1) FI72653C (de)
FR (1) FR2489150A1 (de)
GB (1) GB2083047B (de)
HU (1) HU183542B (de)
IT (1) IT1138511B (de)
LU (1) LU83577A1 (de)
NL (1) NL8103563A (de)
NO (1) NO157884C (de)
SE (1) SE459639B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127603A2 (de) * 1983-05-20 1984-12-05 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Herstellung einer Faktor VIII(AHF)-hältigen Präparation

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555305B2 (en) * 1982-09-29 1986-09-18 Bayer Corporation Antihemophilic factor concentrate
EP0148843B2 (de) * 1983-03-21 1994-05-04 Novo Nordisk A/S Antihämophilie-faktor-viii-konzentrat und dessen herstellungsverfahren
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
CA1293941C (en) * 1985-11-08 1992-01-07 Maria Erlinda Co-Sarno Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
CN116322920A (zh) 2020-11-09 2023-06-23 武田药品工业株式会社 使用氧化硅吸附从血浆中纯化fviii

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
CA1101332A (fr) * 1976-01-30 1981-05-19 Edward Shanbrom Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
DE2624373C2 (de) 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1054052A (en) 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127603A2 (de) * 1983-05-20 1984-12-05 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Herstellung einer Faktor VIII(AHF)-hältigen Präparation
EP0127603A3 (en) * 1983-05-20 1986-09-03 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Process for the preparation of a composition containing a factor viii(ahf)

Also Published As

Publication number Publication date
CA1160567A (en) 1984-01-17
DE3129987A1 (de) 1982-04-22
HU183542B (en) 1984-05-28
JPS5775928A (en) 1982-05-12
FR2489150B1 (de) 1984-06-29
IT8123660A0 (it) 1981-08-27
JPS5928537B2 (ja) 1984-07-13
US4404131A (en) 1983-09-13
DE3129987C2 (de) 1984-11-29
NO157884C (no) 1988-06-15
ATA433880A (de) 1982-05-15
AR228874A1 (es) 1983-04-29
FI72653B (fi) 1987-03-31
NO157884B (no) 1988-02-29
FR2489150A1 (fr) 1982-03-05
SE8104482L (sv) 1982-02-28
ES8302017A1 (es) 1983-01-01
ES504859A0 (es) 1983-01-01
BE890003A (fr) 1981-12-16
LU83577A1 (de) 1981-12-01
FI812567L (fi) 1982-02-28
SE459639B (sv) 1989-07-24
DK156764B (da) 1989-10-02
NL8103563A (nl) 1982-03-16
CH652030A5 (de) 1985-10-31
DK156764C (da) 1990-02-19
DK360281A (da) 1982-02-28
GB2083047B (en) 1984-03-28
FI72653C (fi) 1987-07-10
IT1138511B (it) 1986-09-17
GB2083047A (en) 1982-03-17
NO812905L (no) 1982-03-01

Similar Documents

Publication Publication Date Title
AT388849B (de) Verfahren zur herstellung eines diaet-faserproduktes
AT369990B (de) Verfahren zur herstellung eines gewebeklebstoffes
DE3881077D1 (de) Verfahren zur herstellung eines diamantfilms.
AT369263B (de) Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
AT383813B (de) Verfahren zur herstellung eines neuen aethylenter bzw. -tetrapolymeren
DE3483413D1 (de) Verfahren zur herstellung eines zusammengesetzten bauteiles.
DE3883129D1 (de) Verfahren zur herstellung eines supraleitenden drahtes.
AT372072B (de) Verfahren zur herstellung eines neuen platinisocitrat-komplexes
AT389273B (de) Verfahren zur herstellung eines behaelters
AT376366B (de) Verfahren zur herstellung eines arzneimittels
AT354632B (de) Verfahren zur herstellung eines faktor viii- konzentrates
AT379314B (de) Verfahren zur herstellung eines mehrschichtenskis
AT365417B (de) Verfahren zur herstellung eines protein-konzentrats
ATA259283A (de) Verfahren zur herstellung eines haarwuchsmittels
AT376966B (de) Verfahren zur herstellung eines furanderivats
AT378175B (de) Verfahren zur herstellung eines leichtbaustoffes
AT374343B (de) Verfahren zur herstellung eines salzlecksteines
ATA68382A (de) Verfahren zur herstellung eines gewebeklebstoffes
AT371876B (de) Verfahren zur herstellung eines bauwerkes
AT365805B (de) Verfahren zur herstellung eines magnetkopfes
AT387382B (de) Verfahren zur herstellung eines bromacylprolins
ATA19385A (de) Verfahren zur herstellung eines beutelknoedels
ATA93982A (de) Verfahren zur herstellung eines 3-vinyl-cephalosporins
AT354583B (de) Verfahren zur herstellung eines schmelzhaft- klebers
ATA274085A (de) Verfahren zur herstellung eines furanderivates

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee